Donepezil Therapy in Clinical Practice
Author(s) -
Steven M. Greenberg,
Marsha Tennis,
Laura B. Brown,
Teresa GómezIsla,
Ivor S. Douglas,
David Schoenfeld,
Katie L. Walsh,
Claire Corwin,
Kirk R. Daffner,
Pamela Friedman,
MaryEllen Meadows,
Reisa A. Sperling,
John H. Growdon
Publication year - 2000
Publication title -
archives of neurology
Language(s) - English
Resource type - Journals
eISSN - 1538-3687
pISSN - 0003-9942
DOI - 10.1001/archneur.57.1.94
Subject(s) - donepezil , placebo , rivastigmine , medicine , clinical global impression , tacrine , dementia , randomized controlled trial , adverse effect , nausea , alzheimer's disease , crossover study , verbal fluency test , psychology , psychiatry , cognition , disease , neuropsychology , biochemistry , chemistry , alternative medicine , pathology , acetylcholinesterase , enzyme
To determine the efficacy of donepezil hydrochloride for the treatment of Alzheimer disease in patients drawn from clinical practice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom